GTX Inc. (NASDAQ:GTXI) was a big mover last session, as its shares rose over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the company since Apr 7, as the stock is now trading above the volatile price range of $1.32 to $1.50. GTx, Inc. (NASDAQ:GTXI) stock performance was -3.33% in last session and finished the day at $1.45. Traded volume was 353,850.00million shares in the last session and the average volume of the stock remained 541.94K shares. The beta of the stock remained 1.19. GTx, Inc. (NASDAQ:GTXI) insider ownership is 43.60%.

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that Paul Berns, the company’s President and Chief Executive Officer, will provide a company overview at Deutsche Bank’s 39th Annual Health Care Conference on Thursday, May 8, 2014 at 10:40 a.m. ET in Boston, Massachusetts. Anacor Pharmaceuticals Inc (NASDAQ:ANAC) rose 6.26 percent to $17.65 Monday on volume of 402,646.00million shares. The intra-day range of the stock was $16.28 to $17.87. Anacor Pharmaceuticals Inc (NASDAQ:ANAC) has a market capitalization of $738.45million.

One of the Purple Palace’s offerings will come from Emmy-nominated director Paul Feig, who was behind cult TV show Freaks and Geeks and popular comedy movieBridesmaids. Other Space will be a galactic adventure set in the early 22nd century Group Inc (NYSEMKT:XXII) and featuring a group of misfits that discovers an alternate universe. 22nd Century Group Inc (NYSEMKT:XXII)’s stock on May 5, 2014 reported a decrease of -4.64% to the closing price of $2.67. Its fifty two weeks range is $0.52 -$6.36. The total market capitalization recorded $155.53million. The overall volume in the last trading session was 452,438.00million shares. In its share capital, XXII has 58.68million outstanding shares.

Trade-Ideas LLC identified Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) as a “perilous reversal” (up big yesterday but down big today) candidate. TheStreet Quant Ratings rates Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) as a sell. On Monday, shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) dropped -3.24% to close the day at $14.04. Company return on investment (ROI) is -46.30% and its monthly performance is recorded as -16.18%. Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) quarterly revenue growth is 26.37%.